Skip to main content
Clinical Trials/NCT03562481
NCT03562481
Completed
Phase 4

Pilot Study: Comparison of Buffered 1% vs. Unbuffered 2% Lidocaine in Pediatric Subjects; Clinical Outcomes

University of North Carolina, Chapel Hill1 site in 1 country26 target enrollmentJuly 24, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Anesthesia, Local
Sponsor
University of North Carolina, Chapel Hill
Enrollment
26
Locations
1
Primary Endpoint
Mean Pain Scores Following Injection
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Local anesthesia is an integral part of clinical pediatric dental practice, but it has challenges. It can be uncomfortable for children, and the risk of adverse events limits how much is used. Some evidence suggests benefits of buffering local anesthetics including equal effect with less pain on injection. These findings have not been replicated and validated among pediatric populations, creating a gap in the knowledge base. To address this knowledge gap and contribute to the evidence base on safety and efficacy of local anesthesia in pediatric dentistry, this investigation proposes to compare the anesthetic effects of buffered 1% lidocaine with those of unbuffered 2%, among children.

The specific aims of this investigation are to determine differences between buffered 1% and unbuffered 2% lidocaine (both with 1:100,000 epinephrine) used for inferior alveolar nerve block (IAN) anesthesia, in the following domains:

  1. Pain experience on injection, time to onset following the administration, and time to recovery [subjective]
  2. Blood lidocaine levels 15 minutes following the administration and duration of pulpal anesthesia [objective]

Null Hypotheses:

  1. No difference exists in anesthetic effectiveness for pulpal anesthesia after intraoral IAN block between buffered 1% Lidocaine with 1:100,000 epinephrine as compared to unbuffered 2% Lidocaine with 1:100,000 epinephrine.
  2. No differences exist in peak blood lidocaine levels, pain on injection, time to lip numbness, and duration of anesthesia between the two drug formulations.

Randomized subjects will be injected orally for bottom jaw anesthesia, with 3cc of buffered 1% lidocaine (30mg) 1:100,000 epinephrine or 3cc unbuffered of 2% lidocaine (60mg) 1:100,000 epinephrine. The injectable volume of the buffered formulation will include 0.3cc of 8.4% sodium bicarbonate.

One faculty member in the Department of Pediatric Dentistry at the University of North Carolina (UNC) School of Dentistry will administer the drugs in the Pediatric Dentistry clinic. The same clinician will administer injection to the same subjects at both visits. Clinicians and subjects will not know which drug formulation is given at which appointment.

A clinician will measure the level of discomfort on injection, how long it takes for the lip to be numb, how long it takes for the first molar tooth in that area to be numb, how long it takes the local anesthetic to wear off, and how much of the anesthetic is in the blood.

Registry
clinicaltrials.gov
Start Date
July 24, 2018
End Date
June 30, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 10-12 years
  • American Society of Anesthesiologists (ASA) Class I (Healthy)
  • Body Weight: the Interquartile Range (IQR) 33-60Kg for subject ages
  • Have ability to speak and read English
  • Willingness to participate in two sessions
  • No history of adverse reaction to dental anesthetic
  • Have bilateral, disease/symptom-free mandibular first molars present

Exclusion Criteria

  • Allergy to lidocaine class of anesthetic drugs
  • Local anesthetic drug use in past week
  • Current symptomatic teeth or oral mucosa
  • ASA II or above (including asthma)

Outcomes

Primary Outcomes

Mean Pain Scores Following Injection

Time Frame: Within 10 minutes of injection

Perceived pain on injection, self-reported verbally using a Likert scale from 1-10, with lower numbers corresponding to less pain (1 = "no pain," 10 = "worst pain imaginable"). Lower scores reflect a lesser degree of pain.

Mean Time to Lower Lip Numbness Following Injection

Time Frame: Up to 30 minutes following injection

Time in minutes beginning immediately following injection to patient-reported lip numbness

Average Serum Lidocaine Concentration at 15 Minutes Post Injection

Time Frame: One blood draw taken 15 minutes following injection

Blood Lidocaine Level (mcg/mL) as measured in 10cc venous blood, taken 15 minutes following injection. Blood assayed for serum lidocaine levels with a Sciex TripleTOF liquid chromatography- mass spectrometry (LC-MS) equipped with a C18 Hypersil (10mm x 2.1mm, 3.0μm).

Mean Time to Baseline Lip Sensation

Time Frame: Within 24 hours following injection

Response in minutes from injection to when lip is no longer numb, as self reported by patient.

Number of Participants Who Respond to Cold Stimulus (Positive/Negative) Prior to Injection

Time Frame: 5 minutes prior to injection

Response to experiencing sensation to cold stimulus on permanent molar tooth prior to injection

Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 90 Minutes Following Injection

Time Frame: 90 minutes following injection

Response to experiencing sensation to cold stimulus on permanent molar tooth 90 minutes following injection

Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 120 Minutes Following Injection

Time Frame: 120 minutes following injection

Response to experiencing sensation to cold stimulus on permanent molar tooth 120 minutes following injection

Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 30 Minutes Following Injection

Time Frame: 30 minutes following injection

Response to experiencing sensation to cold stimulus on permanent molar tooth 30 minutes following injection

Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 60 Minutes Following Injection

Time Frame: 60 minutes following injection

Response to experiencing sensation to cold stimulus on permanent molar tooth 60 minutes following injection

Study Sites (1)

Loading locations...

Similar Trials